La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Medical Data Vision Gestion

Gestion contrôle des critères 1/4

We currently do not have sufficient information about the CEO.

Informations clés

Hiroyuki Iwasaki

Directeur général

n/a

Rémunération totale

Pourcentage du salaire du PDG	n/a
Durée du mandat du directeur général	9.9yrs
Propriété du PDG	2.1%
Durée moyenne d'occupation des postes de direction	pas de données
Durée moyenne du mandat des membres du conseil d'administration	8.4yrs

Mises à jour récentes de la gestion

Recent updates

Medical Data Vision (TSE:3902) Has Affirmed Its Dividend Of ¥6.50

Aug 10

Medical Data Vision Co., Ltd. (TSE:3902) Stocks Shoot Up 25% But Its P/E Still Looks Reasonable

Jun 25

Why Medical Data Vision Co., Ltd. (TSE:3902) Could Be Worth Watching

Jun 13

PDG

Hiroyuki Iwasaki (64 yo)

9.9yrs

Titularisation

Mr. Hiroyuki Iwasaki has been the President and Representative Director of Medical Data Vision Co., Ltd. since September 2014 and serves as its Chairman. Mr. Hiroyuki Iwasaki joined Shin Nihonkokan Co., Lt...

Membres du conseil d'administration

Nom	Position	Titularisation	Compensation	Propriété
Hiroyuki Iwasaki	Chairman & President	9.9yrs	pas de données	2.1% ¥ 388.3m
Syuuji Asami	Senior MD	21yrs	pas de données	0.23% ¥ 43.3m
Takuji Yanagisawa	GM of Business Planning Division	16.1yrs	pas de données	0.22% ¥ 39.9m
Masaki Nakamura	GM of the Alliance Promotion Office & Director	6.4yrs	pas de données	0.0034% ¥ 635.4k
Soichi Katsuki	Independent Outside Director	8.4yrs	pas de données	0.042% ¥ 7.8m
Kiyohito Hamada	Independent Outside Audit & Supervisory Board Member	10.4yrs	pas de données	pas de données
Osamu Nakagawa	Audit & Supervisory Board Member	11.4yrs	pas de données	pas de données
Takao Nakamura	Independent Outside Director	5.4yrs	pas de données	pas de données
Yasunori Matsumoto	Independent Outside Audit & Supervisory Board Member	6.4yrs	pas de données	pas de données
Masaaki Takaki	Independent Outside Full-Time Audit & Supervisory Board Member	2.4yrs	pas de données	pas de données
Kiyomi Nojiro	Independent Outside Director	less than a year	pas de données	pas de données

8.4yrs

Durée moyenne de l'emploi

61yo

Âge moyen

Conseil d'administration expérimenté: 3902's board of directors are considered experienced (8.4 years average tenure).

Medical Data Vision Gestion

Gestion contrôle des critères 1/4

Informations clés

Mises à jour récentes de la gestion

Medical Data Vision Co., Ltd., Annual General Meeting, Mar 27, 2024

Medical Data Vision Co., Ltd., Annual General Meeting, Mar 28, 2023

Less than half of directors are independent

Less than half of directors are independent

Medical Data Vision Co., Ltd., Annual General Meeting, Mar 29, 2022

Medical Data Vision Co., Ltd., Annual General Meeting, Mar 23, 2021

Recent updates

New minor risk - Profit margin trend

Medical Data Vision (TSE:3902) Has Affirmed Its Dividend Of ¥6.50

Dividend of JP¥6.50 announced

New major risk - Share price stability

Investor sentiment deteriorates as stock falls 21%

Medical Data Vision Co., Ltd. (TSE:3902) Stocks Shoot Up 25% But Its P/E Still Looks Reasonable

Medical Data Vision Co., Ltd. to Report Q2, 2024 Results on Aug 08, 2024

Why Medical Data Vision Co., Ltd. (TSE:3902) Could Be Worth Watching

New minor risk - Share price stability

First quarter 2024 earnings released: JP¥0.39 loss per share (vs JP¥7.20 profit in 1Q 2023)

Now 21% overvalued

Now 22% overvalued

Medical Data Vision Co., Ltd. to Report Q1, 2024 Results on May 13, 2024

Full year 2023 earnings released: EPS: JP¥25.63 (vs JP¥22.75 in FY 2022)

Medical Data Vision Co., Ltd., Annual General Meeting, Mar 27, 2024

Now 21% undervalued after recent price drop

Now 20% undervalued after recent price drop

Medical Data Vision Co., Ltd. to Report Fiscal Year 2023 Results on Feb 13, 2024

Upcoming dividend of JP¥6.50 per share at 1.1% yield

Now 23% undervalued after recent price drop

Third quarter 2023 earnings released: EPS: JP¥5.60 (vs JP¥6.65 in 3Q 2022)

Now 21% undervalued after recent price drop

Medical Data Vision Co., Ltd. to Report Q3, 2023 Results on Nov 13, 2023

Now 23% undervalued after recent price drop

New minor risk - Profit margin trend

Second quarter 2023 earnings released: EPS: JP¥4.45 (vs JP¥5.47 in 2Q 2022)

Price target decreased by 14% to JP¥815

Medical Data Vision Co., Ltd. to Report Q2, 2023 Results on Aug 10, 2023

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 16%

First quarter 2023 earnings released: EPS: JP¥7.20 (vs JP¥8.16 in 1Q 2022)

Medical Data Vision Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2023

Full year 2022 earnings: EPS and revenues miss analyst expectations

Full year 2022 earnings: EPS and revenues miss analyst expectations

Medical Data Vision Co., Ltd. Provides Dividend Guidance for the Year Ending December 31, 2023

Price target decreased by 15% to JP¥1,010

Medical Data Vision Co., Ltd., Annual General Meeting, Mar 28, 2023

Medical Data Vision Co., Ltd. to Report Fiscal Year 2022 Results on Feb 13, 2023

Upcoming dividend of JP¥6.00 per share

Less than half of directors are independent

Medical Data Vision Co., Ltd. Provides Dividend Guidance for the Year Ending December 31, 2022

Medical Data Vision Co., Ltd. to Report Q3, 2022 Results on Nov 14, 2022

Medical Data Vision Provides Dividend Guidance for the Fiscal Year Ending December 31, 2022

Second quarter 2022 earnings released: EPS: JP¥5.47 (vs JP¥4.47 in 2Q 2021)

Medical Data Vision Co., Ltd. to Report Q2, 2022 Results on Aug 08, 2022

First quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Medical Data Vision Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2022

Price target decreased to JP¥1,220

Less than half of directors are independent

Medical Data Vision Co., Ltd. to Report Q1, 2022 Results on May 12, 2022

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Medical Data Vision Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2022

Medical Data Vision Co., Ltd., Annual General Meeting, Mar 29, 2022

Medical Data Vision Co., Ltd. (TSE:3902) announces an Equity Buyback for 800,000 shares, representing 2.05% for ¥1,000 million.

Upcoming dividend of JP¥5.00 per share

Price target decreased to JP¥2,275

Third quarter 2021 earnings released: EPS JP¥5.49 (vs JP¥5.28 in 3Q 2020)

Medical Data Vision Co., Ltd. (TSE:3902) announces an Equity Buyback for 200,000 shares, representing 0.51% for ¥345 million.

Second quarter 2021 earnings released: EPS JP¥4.47 (vs JP¥4.26 in 2Q 2020)

First quarter 2021 earnings released: EPS JP¥7.84 (vs JP¥3.80 in 1Q 2020)

New 90-day low: JP¥2,031

Analysts lower EPS estimates to JP¥20.80

Full year 2020 earnings released: EPS JP¥17.72 (vs JP¥13.84 in FY 2019)

Revenue and earnings miss expectations

Medical Data Vision Co., Ltd., Annual General Meeting, Mar 23, 2021

New 90-day low: JP¥2,311

Price target raised to JP¥2,265

Medical Data Vision Co., Ltd. to Report Q3, 2020 Results on Nov 09, 2020

Medical Data Vision Co., Ltd. (TSE:3902) closed the acquisition of Medical Domain Inc. from Michio Nagashima.